The Real Stock Market Wealth Is Made... At 3pm!
Steady gains in 18 hours?? Pro traders call this the 3PM “burn window”… ACCESS NOW!
Continue Reading
pixel

TPTX Insider Trading (Turning Point Therapeutics)

Insider Ownership Percentage: 23.20%
Insider Buying (Last 12 Months): $249,960.00
Insider Selling (Last 12 Months): $25,197,518.71

Turning Point Therapeutics Insider Trading History Chart

Turning Point Therapeutics Share Price & Price History

$78.95
▼ -3.11 (-3.79%)
As of 04/9/2021 01:00 AM ET
Days: 30 | 90 | 365
Gain the Knowledge You Need to Successfully Trade Futures Markets
Our Technical Analysis Guide will give you the insight into today’s fast-moving markets. It’s designed to give you a head start in learning the basics of various TA tools and techniques.
Download Your Complimentary Technical Analysis Guide TODAY!
pixel

Turning Point Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/23/2021Brian Lee BakerSVPSell28,435$100.65$2,861,982.754,116  
3/4/2021Siegfried ReichEVPSell35,550$105.04$3,734,172.0039,395  
2/11/2021Athena CountouriotisCEOSell8,942$137.38$1,228,451.9668,195  
2/9/2021Athena CountouriotisCEOSell25,666$138.68$3,559,360.8868,195  
2/1/2021Annette NorthEVPSell15,984$123.65$1,976,421.6015,984  
2/1/2021Yi LarsonCFOSell15,702$123.62$1,941,081.24  
1/7/2021Brian Lee BakerSVPSell31,238$122.26$3,819,157.88  
1/5/2021Mohammad HirmandEVPSell1,253$120.00$150,360.00  
6/8/2020Jingrong Jean CuiDirectorSell18,500$63.45$1,173,825.001,001,298  
6/4/2020Jingrong Jean CuiDirectorSell18,500$64.80$1,198,800.001,001,298  
5/21/2020Athena CountouriotisCEOBuy4,166$60.00$249,960.0026,872  
5/21/2020Jingrong Jean CuiDirectorSell7,000$59.65$417,550.001,001,298  
5/19/2020Jingrong Jean CuiDirectorSell7,000$57.73$404,110.001,001,298  
5/7/2020Jingrong Jean CuiDirectorSell18,500$52.86$977,910.001,001,298  
5/5/2020Jingrong Jean CuiDirectorSell18,500$54.02$999,370.001,001,298  
4/24/2020Jingrong Jean CuiDirectorSell7,000$51.01$357,070.001,001,298  
4/22/2020Jingrong Jean CuiDirectorSell7,000$51.78$362,460.001,001,298  
4/13/2020Jingrong Jean CuiDirectorSell708$50.05$35,435.401,001,298  
4/8/2020Jingrong Jean CuiDirectorSell18,500$46.25$855,625.001,001,298  
4/6/2020Jingrong Jean CuiDirectorSell18,500$43.51$804,935.001,001,298  
3/25/2020Jingrong Jean CuiDirectorSell17,792$45.42$808,112.641,001,298  
3/23/2020Jingrong Jean CuiDirectorSell7,000$38.39$268,730.001,001,298  
3/12/2020Jingrong Jean CuiDirectorSell7,000$36.08$252,560.00  
3/10/2020Jingrong Jean CuiDirectorSell18,500$42.28$782,180.00  
2/26/2020Jingrong Jean CuiDirectorSell7,000$51.43$360,010.001,301,298  
2/24/2020Jingrong Jean CuiDirectorSell7,000$53.70$375,900.001,301,298  
2/12/2020Jingrong Jean CuiDirectorSell18,500$65.92$1,219,520.001,301,298  
2/10/2020Jingrong Jean CuiDirectorSell18,500$62.94$1,164,390.001,301,298  
1/29/2020Jingrong Jean CuiInsiderSell7,000$58.73$411,110.001,301,298  
1/27/2020Jingrong Jean CuiInsiderSell7,000$57.66$403,620.001,301,298  
1/15/2020Jingrong Jean CuiInsiderSell11,500$53.12$610,880.001,301,298  
1/13/2020Jingrong Jean CuiInsiderSell18,500$52.87$978,095.001,301,298  
1/10/2020Jingrong Jean CuiInsiderSell18,500$57.68$1,067,080.001,301,298  
12/20/2019Jingrong Jean CuiInsiderSell11,500$63.40$729,100.001,301,298  
12/18/2019Jingrong Jean CuiInsiderSell18,500$59.20$1,095,200.001,301,298  
12/16/2019Jingrong Jean CuiInsiderSell11,500$58.35$671,025.001,301,298  
12/13/2019Jingrong Jean CuiInsiderSell11,500$55.75$641,125.001,301,298  
12/11/2019Jingrong Jean CuiInsiderSell11,500$52.94$608,810.00  
12/9/2019Jingrong Jean CuiInsiderSell11,500$55.32$636,180.001,301,298  
12/5/2019Jingrong Jean CuiInsiderSell56,110$51.95$2,914,914.501,301,298  
9/10/2019Athena CountouriotisCEOBuy10,000$45.00$450,000.00
9/10/2019Simeon GeorgeDirectorBuy177,777$45.00$7,999,965.00
9/10/2019Yi LarsonCFOBuy2,222$45.00$99,990.00
4/22/2019Athena CountouriotisCEOBuy12,000$18.00$216,000.00  
4/22/2019Brian Lee BakerVPBuy2,800$18.00$50,400.00  
4/22/2019Carl L GordonDirectorBuy360,000$18.00$6,480,000.00  
4/22/2019Cormorant Asset Management, LpMajor ShareholderBuy400,000$18.00$7,200,000.00  
See Full Table

SEC Filings (Institutional Ownership Changes) for Turning Point Therapeutics (NASDAQ:TPTX)

81.31% of Turning Point Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Turning Point Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
4/5/2021Pacer Advisors Inc.678$64K0.0%-39.0%0.001%
3/12/2021DekaBank Deutsche Girozentrale15,350$1.85M0.0%-32.1%0.031%
3/8/2021Teachers Retirement System of The State of Kentucky11,632$1.42M0.0%-17.7%0.024%
3/8/2021Dimensional Fund Advisors LP24,206$2.95M0.0%N/A0.049%
3/2/2021Norges Bank397,718$48.46M0.0%N/A0.826%
3/1/2021UBS Asset Management Americas Inc.36,661$4.47M0.0%+29.3%0.076%
2/25/2021Dimensional Fund Advisors LP24,206$2.95M0.0%N/A0.050%
2/25/2021Hsbc Holdings PLC3,634$0.45M0.0%N/A0.008%
2/24/2021Virtu Financial LLC6,105$0.74M0.1%N/A0.013%
2/23/2021WCM Investment Management LLC53,316$6.50M0.0%+50.9%0.111%
2/23/2021Principal Financial Group Inc.17,689$2.16M0.0%+40.6%0.037%
2/19/2021JPMorgan Chase & Co.47,719$5.82M0.0%+52.0%0.099%
2/19/2021International Biotechnology Trust PLC113,541$13.82M3.8%+224.4%0.236%
2/18/2021Truist Financial Corp3,187$0.39M0.0%N/A0.007%
2/17/2021Voloridge Investment Management LLC6,878$0.84M0.0%-88.4%0.014%
2/17/2021Castleark Management LLC74,807$9.12M0.3%-20.7%0.155%
2/17/2021Jane Street Group LLC22,880$2.79M0.0%+84.7%0.047%
2/16/2021Silverarc Capital Management LLC16,131$1.97M1.1%N/A0.033%
2/16/2021Squarepoint Ops LLC1,710$0.21M0.0%-65.1%0.004%
2/16/2021Morgan Stanley51,038$6.22M0.0%+439.1%0.106%
2/16/2021Tudor Investment Corp Et Al9,172$1.12M0.0%N/A0.019%
2/16/2021Nuveen Asset Management LLC195,011$23.76M0.0%+3.2%0.405%
2/16/2021WCM Investment Management LLC53,316$6.50M0.0%+50.9%0.111%
2/16/2021Guggenheim Capital LLC4,220$0.51M0.0%N/A0.009%
2/16/2021Price T Rowe Associates Inc. MD2,545,785$310.20M0.0%+30.4%5.285%
2/16/2021ExodusPoint Capital Management LP4,102$0.50M0.0%+38.9%0.009%
2/16/2021Charles Schwab Investment Management Inc.269,243$32.81M0.0%+14.7%0.559%
2/13/2021American International Group Inc.21,704$2.65M0.0%+6.3%0.045%
2/12/2021Stifel Financial Corp5,878$0.72M0.0%N/A0.012%
2/12/2021Allstate Corp2,609$0.32M0.0%-13.8%0.005%
2/12/2021Penserra Capital Management LLC1,110$0.14M0.0%+208.3%0.002%
2/12/2021Federated Hermes Inc.813,462$99.12M0.2%+28.4%1.689%
2/12/2021Amalgamated Bank5,638$0.69M0.0%+10.2%0.012%
2/12/2021The Manufacturers Life Insurance Company22,147$2.70M0.0%+13.6%0.046%
2/12/2021Advisory Research Inc.8,666$1.06M0.1%-20.0%0.018%
2/12/2021Credit Suisse AG811,362$98.86M0.0%+46.0%1.684%
2/12/2021Vontobel Holding Ltd.3,115$0.44M0.0%N/A0.006%
2/12/2021Kennedy Capital Management Inc.17,455$2.13M0.0%-1.0%0.036%
2/12/2021Virtus ETF Advisers LLC2,333$0.28M0.1%-53.7%0.005%
2/11/2021Lazard Asset Management LLC572$69K0.0%N/A0.001%
2/11/2021Northern Trust Corp438,112$53.38M0.0%+8.2%0.909%
2/11/2021First Mercantile Trust Co.1,364$0.17M0.0%+32.4%0.003%
2/11/2021Barclays PLC13,725$1.67M0.0%-19.8%0.028%
2/11/2021Citigroup Inc.26,529$3.23M0.0%+34.4%0.055%
2/11/2021Handelsbanken Fonder AB140,400$17.11M0.1%-20.0%0.291%
2/11/2021Artal Group S.A.350,000$42.65M0.9%+7.7%0.727%
2/11/2021Teacher Retirement System of Texas3,637$0.44M0.0%N/A0.008%
2/11/2021Oppenheimer Asset Management Inc.2,015$0.25M0.0%N/A0.004%
2/11/2021Nicholas Investment Partners LP183,676$22.38M1.7%+0.2%0.381%
2/10/2021Rhumbline Advisers46,821$5.71M0.0%+14.4%0.097%
2/10/2021Renaissance Technologies LLC34,100$4.16M0.0%-64.9%0.071%
2/10/2021QS Investors LLC3,300$0.40M0.0%+32.0%0.007%
2/10/2021Aviva PLC14,843$1.81M0.0%-44.8%0.031%
2/10/2021Lisanti Capital Growth LLC69,125$8.42M1.2%+9.9%0.143%
2/9/2021Wells Fargo & Company MN631,500$76.95M0.0%+3.4%1.311%
2/9/2021Fiera Capital Corp36,271$4.42M0.0%-1.4%0.075%
2/9/2021Bank of New York Mellon Corp170,107$20.73M0.0%+11.2%0.353%
2/9/2021Lord Abbett & CO. LLC1,318,298$160.64M0.4%+55.7%2.737%
2/9/2021Matthews International Capital Management LLC69,800$8.51M0.5%-40.8%0.145%
2/9/2021Chartwell Investment Partners LLC4,923$0.60M0.0%-18.5%0.010%
2/9/2021ProShare Advisors LLC15,705$1.91M0.0%+43.0%0.033%
2/8/2021Alliancebernstein L.P.945,411$115.20M0.1%-12.4%1.963%
2/8/2021State Board of Administration of Florida Retirement System14,243$1.74M0.0%+21.9%0.030%
2/8/2021New York State Common Retirement Fund55,706$6.79M0.0%+10.8%0.116%
2/8/2021Sei Investments Co.16,180$1.97M0.0%-6.1%0.034%
2/8/2021Primecap Management Co. CA451,340$55M0.0%+2.2%0.937%
2/8/2021FMR LLC6,215,363$757.34M0.1%-1.7%12.902%
2/8/2021Russell Investments Group Ltd.40,477$4.93M0.0%+55.4%0.084%
2/6/2021Jennison Associates LLC832,596$101.45M0.1%+31.7%1.728%
2/5/2021BlackRock Inc.3,157,387$384.73M0.0%+16.8%6.554%
2/5/2021Aperio Group LLC2,666$0.33M0.0%N/A0.006%
2/5/2021Swiss National Bank90,000$10.97M0.0%+17.8%0.187%
2/5/2021Syquant Capital Sas5,000$0.61M0.2%N/A0.010%
2/5/2021SG Americas Securities LLC21,573$2.63M0.0%+233.2%0.045%
2/4/2021Los Angeles Capital Management LLC17,527$2.14M0.0%+1.0%0.036%
2/4/2021State of Wisconsin Investment Board54,200$6.60M0.0%+10.8%0.113%
2/3/2021State of New Jersey Common Pension Fund D22,991$2.80M0.0%N/A0.048%
2/2/2021California Public Employees Retirement System91,930$11.20M0.0%+23.5%0.191%
2/2/2021First Trust Advisors LP50,178$6.11M0.0%+25.7%0.104%
2/1/2021Victory Capital Management Inc.69,684$8.49M0.0%+100.7%0.145%
1/29/2021Emerald Mutual Fund Advisers Trust336,173$40.96M1.4%+19.0%0.698%
1/29/2021Emerald Advisers LLC357,038$43.51M1.4%+19.4%0.741%
1/28/2021Arizona State Retirement System11,528$1.41M0.0%+13.3%0.024%
1/28/2021Zurcher Kantonalbank Zurich Cantonalbank5,128$0.63M0.0%+37.6%0.011%
1/27/2021Calamos Advisors LLC19,366$2.36M0.0%N/A0.040%
1/25/2021Nisa Investment Advisors LLC1,350$0.16M0.0%+68.8%0.003%
1/25/2021Strs Ohio12,600$1.54M0.0%+3.3%0.026%
1/22/2021Candriam Luxembourg S.C.A.456,946$55.68M0.4%+94.3%0.949%
1/19/2021Frontier Capital Management Co. LLC132,432$16.14M0.1%+2.3%0.275%
1/19/2021Peregrine Capital Management LLC110,585$13.48M0.3%+11.7%0.230%
12/14/2020Strs Ohio12,200$1.07M0.0%-11.6%0.025%
12/4/2020Sei Investments Co.17,238$1.51M0.0%+330.4%0.036%
11/17/2020Voloridge Investment Management LLC59,359$5.19M0.0%N/A0.123%
11/17/2020California State Teachers Retirement System51,676$4.51M0.0%+22.4%0.107%
11/17/2020Jane Street Group LLC12,389$1.08M0.0%+141.6%0.026%
11/17/2020Schonfeld Strategic Advisors LLC19,815$1.73M0.0%+104.7%0.041%
11/16/2020Cubist Systematic Strategies LLC14,825$1.30M0.0%N/A0.031%
11/16/2020Squarepoint Ops LLC4,905$0.43M0.0%N/A0.010%
11/16/2020ExodusPoint Capital Management LP2,954$0.26M0.0%N/A0.006%
11/16/2020Castleark Management LLC94,298$8.24M0.3%-13.5%0.199%
Data available starting January 2016

See Full Table
Turning Point Therapeutics logo
Turning Point Therapeutics, Inc., a clinical-stage precision oncology biopharmaceutical company, engages in designing and developing therapies that target genetic drivers of cancer. It develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer in TKI-naïve and TKI-pretreated patients. The company's lead drug candidate repotrectinib is being evaluated in an ongoing Phase 1/2 trial called TRIDENT-1 for the treatment of patients with ROS1+ advanced non-small-cell lung cancer (NSCLC) and patients with ROS1+, NTRK+, or ALK+ advanced solid tumors. Its pipeline also includes multi-targeted drug candidates TPX-0022, a MET/CSF1R/SRC inhibitor, which is in Phase 1 SHIELD-1 clinical trial for patients with advanced solid tumors harboring genetic alterations in MET; TPX-0046, a RET inhibitor that is in Phase 1/2 clinical trial for patients with advanced solid tumors harboring RET genetic alterations; and TPX-0131, a preclinical ALK inhibitor for advanced non-small-cell lung cancer. The company was founded in 2013 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $78.95
$78.10
$81.66

50 Day Range

MA: $105.27
$80.70
$121.93

52 Week Range

Now: $78.95
$46.75
$141.30

Volume

352,081 shs

Average Volume

325,880 shs

Market Capitalization

$3.87 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.23

Who are the company insiders with the largest holdings of Turning Point Therapeutics?

Turning Point Therapeutics' top insider shareholders include:
  1. Jingrong Jean Cui (Director)
  2. Jingrong Jean Cui (Insider)
  3. Athena Countouriotis (CEO)
  4. Siegfried Reich (EVP)
  5. Annette North (EVP)
  6. Brian Lee Baker (SVP)
  7. Brian Lee Baker (VP)
  8. Carl L Gordon (Director)
  9. Cormorant Asset Management, Lp (Major Shareholder)
  10. Mohammad Hirmand (EVP)
  11. Simeon George (Director)
  12. Yi Larson (CFO)

Who are the major institutional investors of Turning Point Therapeutics?

Turning Point Therapeutics' top institutional shareholders include:
  1. Pacer Advisors Inc. — 0.00%

Which major investors are selling Turning Point Therapeutics stock?

In the last quarter, TPTX stock was sold by these institutional investors:
  1. Pacer Advisors Inc.
Within the previous year, company insiders that have sold Turning Point Therapeutics company stock include:
  1. Jingrong Jean Cui (Director)
  2. Jingrong Jean Cui (Insider)
  3. Athena Countouriotis (CEO)
  4. Siegfried Reich (EVP)
  5. Annette North (EVP)
  6. Brian Lee Baker (SVP)
  7. Brian Lee Baker (VP)
Weird Market Anomaly Helps Ordinary Traders
This little-known stock market signal could help you retire RICH…
Continue Reading
pixel